Genome Editing

For decades, genome engineering relied on techniques that took years to master, required the generation of large and often complex DNA constructs containing selection markers, and could be applied to only a few organisms. However, the ease and effi ciency of current technologies to edit genomes are unprecedented. With the advent of targetable nucleases, most notably the CRISPR-Cas9 technology, genomes of all species are now easily accessible to modifi cations. This advance has provided countless opportunities not only to further our understanding of gene functions and disease mechanisms but also to correct disease-causing mutations, modify crops and livestock, and perhaps modify our environment. This chapter discusses the advances in genome-editing technologies and their current and future applications.

[1]  J. O'neil,et al.  Enrichment of human embryonic stem cell‐derived NKX6.1‐expressing pancreatic progenitor cells accelerates the maturation of insulin‐secreting cells in vivo , 2013, Stem cells.

[2]  Hao Yin,et al.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.

[3]  E. Maestrini,et al.  A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.

[4]  Yanpeng Wang,et al.  Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew , 2014, Nature Biotechnology.

[5]  Alexander Pertsemlidis,et al.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.

[6]  Danwei Huangfu,et al.  Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes. , 2016, Cell stem cell.

[7]  Simone Hahn,et al.  Plant Pathogen Recognition Mediated by Promoter Activation of the Pepper Bs3 Resistance Gene , 2007, Science.

[8]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[9]  David J. Anderson,et al.  Notch signalling controls pancreatic cell differentiation , 1999, Nature.

[10]  Takashi Yamamoto,et al.  Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice , 2015, Genome Biology.

[11]  R. Kanaar,et al.  DNA double-strand break repair: all's well that ends well. , 2006, Annual review of genetics.

[12]  Wei Yan,et al.  Production of Gene‐Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation , 2015, Stem cells.

[13]  S. Kouhpayeh,et al.  Zinc Finger Nuclease: A New Approach to Overcome Beta-Lactam Antibiotic Resistance , 2016, Jundishapur journal of microbiology.

[14]  F. Gleason,et al.  Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA , 2014 .

[15]  R. Harvey,et al.  An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression. , 1996, Development.

[16]  H. Watkins,et al.  Genetic Cardiomyopathies Causing Heart Failure , 2013, Circulation research.

[17]  Kang Zhang,et al.  Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[18]  P. Sanders,et al.  Expression of bacterial genes in plant cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Yinhua Lu,et al.  One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. , 2015, Acta biochimica et biophysica Sinica.

[20]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[21]  T. Opriessnig,et al.  Edinburgh Research Explorer Pigs lacking the scavenger receptor cysteine-rich domain 5 of CD163 are resistant to PRRSV-1 infection , 2018 .

[22]  A. Bang,et al.  Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells , 2011, Nature Biotechnology.

[23]  T. Kamp Recognizing heart cells in a crowd , 2011, Nature Methods.

[24]  Ramsong Chantre Nongpiur,et al.  Genomics Approaches For Improving Salinity Stress Tolerance in Crop Plants , 2016, Current genomics.

[25]  Ewelina Bolcun-Filas,et al.  A Mouse Geneticist’s Practical Guide to CRISPR Applications , 2014, Genetics.

[26]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[27]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[28]  Robert Passier,et al.  Concise Review: Fluorescent Reporters in Human Pluripotent Stem Cells: Contributions to Cardiac Differentiation and Their Applications in Cardiac Disease and Toxicity , 2016, Stem cells.

[29]  Randall J. Platt,et al.  Therapeutic genome editing: prospects and challenges , 2015, Nature Medicine.

[30]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[31]  William H. Majoros,et al.  Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy , 2015, Nature Communications.

[32]  J. Renard,et al.  Differential H4 acetylation of paternal and maternal chromatin precedes DNA replication and differential transcriptional activity in pronuclei of 1-cell mouse embryos. , 1997, Development.

[33]  Danwei Huangfu,et al.  A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells , 2015, Stem cell reports.

[34]  T. Mashimo,et al.  Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform , 2014, Nature Communications.

[35]  I. Hardcastle,et al.  2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK). , 2003, Bioorganic & medicinal chemistry letters.

[36]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[37]  A. Hattersley,et al.  Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3 , 2011, Diabetes.

[38]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[39]  David Baker,et al.  megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering , 2013, Nucleic acids research.

[40]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[41]  Dana Carroll,et al.  Enhancing Gene Targeting with Designed Zinc Finger Nucleases , 2003, Science.

[42]  Jennifer Nichols,et al.  A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages , 2013, Nature Cell Biology.

[43]  P. Rouet,et al.  Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. , 1994, Molecular and cellular biology.

[44]  Steven Lin,et al.  Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery , 2014, eLife.

[45]  P. Duchateau,et al.  A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences , 2006, Nucleic acids research.

[46]  Jian-Kang Zhu,et al.  De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks , 2011, Proceedings of the National Academy of Sciences.

[47]  R. Prather,et al.  Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus , 2016, Nature Biotechnology.

[48]  Y. Fischer,et al.  NANOG Reporter Cell Lines Generated by Gene Targeting in Human Embryonic Stem Cells , 2010, PloS one.

[49]  W. Heyer,et al.  Regulation of homologous recombination in eukaryotes. , 2010, Annual review of genetics.

[50]  D. Lu,et al.  Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells , 2013, Nucleic acids research.

[51]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[52]  L. Sussel,et al.  Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. , 2000, Development.

[53]  Kai Rothkamm,et al.  Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle , 2003, Molecular and Cellular Biology.

[54]  W. Clarke,et al.  Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1 , 1997, Nature Genetics.

[55]  D. Barnes Non-homologous end joining as a mechanism of DNA repair , 2001, Current Biology.

[56]  S. Chandrasegaran,et al.  Custom-designed zinc finger nucleases: What is next? , 2007, Cellular and Molecular Life Sciences.

[57]  W. Cui,et al.  Stably Transfected Human Embryonic Stem Cell Clones Express OCT4‐Specific Green Fluorescent Protein and Maintain Self‐Renewal and Pluripotency , 2005, Stem cells.

[58]  Aaron M Zorn,et al.  Vertebrate endoderm development and organ formation. , 2009, Annual review of cell and developmental biology.

[59]  A. Colman,et al.  Highly enriched cardiomyocytes from human embryonic stem cells. , 2008, Cytotherapy.

[60]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[61]  J. Orange,et al.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.

[62]  Masafumi Mikami,et al.  CRISPR/Cas9-mediated mutagenesis of the RIN locus that regulates tomato fruit ripening. , 2015, Biochemical and biophysical research communications.

[63]  Hidde L Ploegh,et al.  Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise [TM: inserted] genome editing , 2015, Nature Biotechnology.

[64]  Sheng Huang,et al.  TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain , 2010, Nucleic Acids Res..

[65]  F. Gage,et al.  Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs. , 2015, Cell reports.

[66]  J. Karn,et al.  Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing , 2015, Scientific Reports.

[67]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[68]  Tetsushi Sakuma,et al.  Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9 , 2014, Stem cell reports.

[69]  TAL effector nucleases induce mutations at a pre-selected location in the genome of primary barley transformants , 2013, Plant Molecular Biology.

[70]  Simona Casini,et al.  Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.

[71]  S Chandrasegaran,et al.  Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Barrangou,et al.  CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.

[73]  Erin L. Doyle,et al.  Targeting DNA Double-Strand Breaks with TAL Effector Nucleases , 2010, Genetics.

[74]  Seung Woo Cho,et al.  Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. , 2009, Genome research.

[75]  Yong Wang,et al.  Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9 , 2017, Science.

[76]  M. Helmrath,et al.  The Basic Helix-Loop-Helix Transcription Factor NEUROG3 Is Required for Development of the Human Endocrine Pancreas , 2015, Diabetes.

[77]  C. Barbas,et al.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.

[78]  Philippe Horvath,et al.  The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli , 2011, Nucleic acids research.

[79]  K. Pollard,et al.  Human Disease Modeling Reveals Integrated Transcriptional and Epigenetic Mechanisms of NOTCH1 Haploinsufficiency , 2015, Cell.

[80]  Jonathan C. Cohen,et al.  Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. , 2006, American journal of human genetics.

[81]  Wei Tang,et al.  Correction of a genetic disease in mouse via use of CRISPR-Cas9. , 2013, Cell stem cell.

[82]  Christopher M. Vockley,et al.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.

[83]  Pei-Rong Wang,et al.  Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. , 2011, Cell stem cell.

[84]  Yoshitaka Fujihara,et al.  Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA , 2013, Scientific Reports.

[85]  G. Church,et al.  Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. , 2011, Nature biotechnology.

[86]  T. Sonstegard,et al.  Production of hornless dairy cattle from genome-edited cell lines , 2016, Nature Biotechnology.

[87]  Chad W. Euler,et al.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.

[88]  Duhee Bang,et al.  A library of TAL effector nucleases spanning the human genome , 2013, Nature Biotechnology.

[89]  Jan-Peter van Pijkeren,et al.  CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri , 2014, Nucleic acids research.

[90]  T. Shindo,et al.  A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice , 2014, BMC Biotechnology.

[91]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[92]  S. Ehrlich,et al.  Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. , 2005, Microbiology.

[93]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[94]  M. Spalding,et al.  High-efficiency TALEN-based gene editing produces disease-resistant rice , 2012, Nature Biotechnology.

[95]  A. De,et al.  An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression , 2012, Cell.

[96]  A. McCulloch,et al.  Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes , 2009, PloS one.

[97]  Ronnie J Winfrey,et al.  High frequency modification of plant genes using engineered zinc finger nucleases , 2009, Nature.

[98]  Takashi Yamamoto,et al.  Simple knockout by electroporation of engineered endonucleases into intact rat embryos , 2014, Scientific Reports.

[99]  Ho Won Kim,et al.  Low‐Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells , 2015, Stem cells translational medicine.

[100]  David A. Brafman,et al.  Analysis of SOX2-Expressing Cell Populations Derived from Human Pluripotent Stem Cells , 2013, Stem cell reports.

[101]  Y. Doyon,et al.  Precise genome modification in the crop species Zea mays using zinc-finger nucleases , 2009, Nature.

[102]  James A. Thomson,et al.  Homologous recombination in human embryonic stem cells , 2003, Nature Biotechnology.

[103]  M. Bétermier,et al.  Is Non-Homologous End-Joining Really an Inherently Error-Prone Process? , 2014, PLoS genetics.

[104]  G. Warnock,et al.  Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice , 2012, Diabetes.

[105]  G. Schmitz,et al.  Cleavage of yeast and bacteriophage T7 genomes at a single site using the rare cutter endonuclease I-Sce I , 1991, Nucleic Acids Res..

[106]  W. Arber Host-Controlled Modification of Bacteriophage , 1965 .

[107]  S. Hughes,et al.  Altering the Genome by Homologous Recombination , 2010 .

[108]  R. Jaenisch,et al.  One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[109]  T. Sonstegard,et al.  Precision Animal Breeding as a Sustainable , non-GMO Solution for Improving Animal Production and Welfare , 2016 .

[110]  Hans Clevers,et al.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.

[111]  Feng Zhang,et al.  Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system , 2013, Nucleic acids research.

[112]  D. F. Carlson,et al.  Efficient nonmeiotic allele introgression in livestock using custom endonucleases , 2013, Proceedings of the National Academy of Sciences.

[113]  Lia Crotti,et al.  Long-QT syndrome: from genetics to management. , 2012, Circulation. Arrhythmia and electrophysiology.

[114]  Yong Fan,et al.  Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system. , 2014, Stem cells and development.

[115]  E. Rebar,et al.  Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.

[116]  Yunde Zhao,et al.  Engineering Herbicide-Resistant Rice Plants through CRISPR/Cas9-Mediated Homologous Recombination of Acetolactate Synthase. , 2016, Molecular plant.

[117]  Meiru Li,et al.  Reassessment of the Four Yield-related Genes Gn1a, DEP1, GS3, and IPA1 in Rice Using a CRISPR/Cas9 System , 2016, Front. Plant Sci..

[118]  L. Ptaszek,et al.  New tools for genome modification in human embryonic stem cells. , 2007, Cell stem cell.

[119]  Jun Qiao,et al.  Efficient Gene Knockout in Goats Using CRISPR/Cas9 System , 2014, PloS one.

[120]  Lei S. Qi,et al.  Small molecules enhance CRISPR genome editing in pluripotent stem cells. , 2015, Cell stem cell.

[121]  Shinya Yamanaka,et al.  Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. , 2015, Cell stem cell.

[122]  Daniel J. Rader,et al.  Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing , 2014, Circulation research.

[123]  Y. Liu,et al.  Creation of Engineered Human Embryonic Stem Cell Lines Using phiC31 Integrase , 2008, Stem cells.

[124]  S. Ha,et al.  Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases , 2014, Genome research.

[125]  A Klug,et al.  Repetitive zinc‐binding domains in the protein transcription factor IIIA from Xenopus oocytes. , 1985, The EMBO journal.

[126]  Seung Woo Cho,et al.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.

[127]  William L. Clarke,et al.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.

[128]  Yoshitaka Fujihara,et al.  Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes , 2014, Development, growth & differentiation.

[129]  Chad A. Cowan,et al.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. , 2014, Cell stem cell.

[130]  T. Cathomen,et al.  The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. , 2013, Human gene therapy.

[131]  Timothy K Lu,et al.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases , 2014, Nature Biotechnology.

[132]  H. Edlund,et al.  Insulin-promoter-factor 1 is required for pancreas development in mice , 1994, Nature.

[133]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[134]  Jun Zhang,et al.  Generation of gene-modified mice via Cas9/RNA-mediated gene targeting , 2013, Cell Research.

[135]  Y. Arai,et al.  Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering , 2014, Scientific Reports.

[136]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[137]  A. Rizzino Concise Review: The Sox2‐Oct4 Connection: Critical Players in a Much Larger Interdependent Network Integrated at Multiple Levels , 2013, Stem cells.

[138]  Koji Sugiura,et al.  Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease , 2013, Nucleic acids research.

[139]  Dana Carroll,et al.  Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. , 2002, Genetics.

[140]  C. Pabo,et al.  DNA recognition by Cys2His2 zinc finger proteins. , 2000, Annual review of biophysics and biomolecular structure.

[141]  L. Tesson,et al.  Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes , 2015, PloS one.

[142]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[143]  Yu Chen,et al.  Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection , 2015, Scientific Reports.

[144]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[145]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[146]  Jin-Soo Kim,et al.  Genome editing with modularly assembled zinc-finger nucleases , 2010, Nature Methods.

[147]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[148]  Jian‐Kang Zhu,et al.  Precise Editing of a Target Base in the Rice Genome Using a Modified CRISPR/Cas9 System. , 2017, Molecular plant.

[149]  Jiyeon Kweon,et al.  TALENs and ZFNs are associated with different mutation signatures , 2013, Nature Methods.

[150]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[151]  Y. Kan,et al.  Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac , 2014, Genome research.

[152]  Dominik Niopek,et al.  CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. , 2014, Biotechnology journal.

[153]  D. Ovchinnikov,et al.  Isolation of contractile cardiomyocytes from human pluripotent stem-cell-derived cardiomyogenic cultures using a human NCX1-EGFP reporter. , 2015, Stem cells and development.

[154]  Karl-Ludwig Laugwitz,et al.  Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research , 2013, Circulation research.

[155]  M. Lieber,et al.  The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. , 2010, Annual review of biochemistry.

[156]  Agnès E. Ricroch,et al.  Next biotech plants: new traits, crops, developers and technologies for addressing global challenges , 2016, Critical reviews in biotechnology.

[157]  CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? , 2017, Stem Cell Research & Therapy.

[158]  J. Vogel,et al.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III , 2011, Nature.

[159]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[160]  Chad A. Cowan,et al.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.

[161]  F. C. Pan,et al.  Pancreas organogenesis: From bud to plexus to gland , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[162]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[163]  B. Dujon,et al.  Nested chromosomal fragmentation in yeast using the meganuclease I-Sce I: a new method for physical mapping of eukaryotic genomes. , 1992, Nucleic acids research.

[164]  M. Chovanec,et al.  DNA double-strand break repair by homologous recombination. , 2004, Mutation research.

[165]  G. S. Ali,et al.  Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system , 2017, Applied Microbiology and Biotechnology.

[166]  A. C. Chang,et al.  Construction of biologically functional bacterial plasmids in vitro. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[167]  Melissa M. Harrison,et al.  A CRISPR view of development , 2014, Genes & development.

[168]  Dana Carroll,et al.  Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases , 2001, Molecular and Cellular Biology.

[169]  O. Michielin,et al.  Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. , 2003, The Journal of clinical endocrinology and metabolism.

[170]  David I. Wilson,et al.  Beta cell differentiation during early human pancreas development. , 2004, The Journal of endocrinology.

[171]  K. C. K. Lloyd,et al.  Conditional targeting of Ispd using paired Cas9 nickase and a single DNA template in mice , 2014, FEBS open bio.

[172]  S Chandrasegaran,et al.  Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. , 2000, Nucleic acids research.

[173]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[174]  J. Mozoruk,et al.  Oligonucleotide‐directed mutagenesis for precision gene editing , 2015, Plant biotechnology journal.

[175]  A. Das,et al.  CRISPR-Cas based antiviral strategies against HIV-1. , 2017, Virus research.

[176]  CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures , 2018, Scientific Reports.

[177]  Emily Waltz,et al.  Gene-edited CRISPR mushroom escapes US regulation , 2016, Nature.

[178]  A. Marais,et al.  Abstract 340: The C679X Mutation in PCSK9 is Present and Lowers Blood Cholesterol in a Southern African Population , 2006 .

[179]  Jin-Soo Kim,et al.  Generation of cloned adult muscular pigs with myostatin gene mutation by genetic engineering , 2017 .

[180]  David Baltimore,et al.  Chimeric Nucleases Stimulate Gene Targeting in Human Cells , 2003, Science.

[181]  F. Zhang,et al.  Improved soybean oil quality by targeted mutagenesis of the fatty acid desaturase 2 gene family. , 2014, Plant biotechnology journal.

[182]  Philippe Horvath,et al.  The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA , 2010, Nature.

[183]  Xiuping Zou,et al.  Engineering canker‐resistant plants through CRISPR/Cas9‐targeted editing of the susceptibility gene CsLOB1 promoter in citrus , 2017, Plant biotechnology journal.

[184]  Jere Weltner,et al.  Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation , 2015, Stem cell reports.

[185]  K. Musunuru Genome editing of human pluripotent stem cells to generate human cellular disease models , 2013, Disease Models & Mechanisms.